SCHEMBL23308

SCHEMBL23308

O=C[C@@H](O)[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL799754 1.00
SCHEMBL15281293 1.00
SCHEMBL424699 1.00
SCHEMBL21114435 1.00 AKR1B1 (0.50)
SCHEMBL21114434 1.00 AKR1B1 (0.50)
SCHEMBL42624 1.00
SCHEMBL117909 1.00
SCHEMBL15321644 1.00 AKR1B1 (0.50)
Methane SCHEMBL23200369 0.97
E968 SCHEMBL18341323 0.97 AKR1B1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 28053 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752148-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING TEIXOBACTIN AND A PEGYLATED PHOSPHOLIPID, AND THEIR USE IN TREATING BACTERIAL INFECTION NOVOBIOTIC PHARMACEUTICALS LLC (US) 2026-05-27 EP claimed
CN-122080919-A Synthesis and application of non-natural nucleic acid fluorescent probe for targeting small molecule toxin 2026-05-26 CN claimed
US-20260137806-A1 INTERCALATING SUGAR MOLECULES XALUD THERAPEUTICS, INC. (US) 2026-05-21 US claimed
WO-2026107335-A1 COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASES BY INHIBITING EFHD1 UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2026-05-21 WO claimed
CN-122056308-A Fermented milk and method for producing fermented milk 内蒙古伊利实业集团股份有限公司 2026-05-19 CN claimed
CN-122060819-A Preparation method of threose nucleic acid based on self-pairing primer template 南京大学 2026-05-19 CN claimed
US-20260130404-A1 SWEETNESS AND TASTE IMPROVEMENT OF NON-SUCROSE SWEETENERS WITH D-SUGARS OR L-SUGARS THE COCA COLA CO (US) 2026-05-14 US claimed
US-20260132404-A1 MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS ALNYLAM PHARMACEUTICALS, INC. (US) 2026-05-14 US claimed
US-12622889-B2 S-β-hydroxybutyrate esters for improving metabolic function AXCESS GLOBAL SCIENCES, LLC (US) 2026-05-12 US claimed
EP-3813785-B1 5-OXAZOLIDINE-2,4-DIONE C-GLYCOSIDE DERIVATIVES AND THEIR USE AS MOISTURIZER FOR THE SKIN OREAL (FR) 2026-05-06 EP claimed
EP-0235085-A1 13-Beta-sugar derivatives of milbemycine, their preparation and use as ekto- and endo-parasitic agents for treatment of animals and plants CIBA-GEIGY AG (CH) 1987-09-02 EP claimed
EP-0233816-A1 Process for the oxidation of aldoses and a catalyst therefor Roquette Frˬres (FR) 1987-08-26 EP claimed
EP-0221728-A2 Monosaccharide containing wound healing preparation Silvetti, Anthony N., Sr. (US) 1987-05-13 EP claimed
EP-0212400-A2 Method for the preparation of sphingosin derivatives Solco Basel AG (CH) 1987-03-04 EP claimed
EP-0151577-A1 NEW GLUCIDIC DERIVATIVES OF 5-HYDROXYTRYPTOPHANE, OBTENTION AND APPLICATION AS DRUGS. OEUVRES HOSPITALIERES FRANCAIS (FR) 1985-08-21 EP claimed
EP-0133795-A1 Gaba esters and gaba analogue esters THE McLEAN HOSPITAL CORPORATION (US) 1985-03-06 EP claimed
WO-1985000520-A1 GABA ESTERS AND GABA ANALOGUE ESTERS THE MCLEAN HOSPITAL CORPORATION (US) 1985-02-14 WO claimed
WO-1984004310-A1 NEW GLUCIDIC DERIVATIVES OF 5-HYDROXYTRYPTOPHANE, OBTENTION AND APPLICATION AS DRUGS MALTE OEUVRES HOSPITAL FSE (FR) 1984-11-08 WO claimed
US-4460767-A COPPER COMPOUND, CHLORIDE OR BROMIDE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1984-07-17 US claimed
US-4439414-A 1-11 C-D-Glucose and related compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1984-03-27 US claimed